10月9日，Hims & Hers Health Inc.盘中上涨5.2%，报29.5197美元/股，成交额7465.72万美元。此前一日公司因FTC诉讼披露引发股价下跌，并面临证券欺诈集体诉讼，投资者可申报损失，市场担忧诉讼风险进一步扩大。
消息面上，公司及高管因FTC诉讼披露引发证券欺诈集体诉讼，投资者可申报损失。此前公司在近三年调查期间向FTC提交大量实质性证据，公司声明指控忽视这些证据，并称将积极捍卫自身权益，坚决驳斥无根据的指控。市场在消化集体诉讼担忧后出现情绪修复，推动股价反弹。
Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员连接起来，提供心理健康、性健康、皮肤病学、头发护理等高质量医疗服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.